A shifting landscape: what will be next FDG in PET oncology?

Annals of Nuclear Medicine
Tomio InoueKeigo Endo

Abstract

The tumor-seeking agent most widely used in positron emission tomography (PET) is 2-(18)F-fluorodeoxy-D-glucose (FDG). The clinical usefulness of FDG PET has already been proved in detecting, staging and restaging various kinds of malignant tumors, but nuclear medicine physicians suffer from a "diagnostic dilemma," in which a relatively high false positive ratio of FDG PET in diagnosing malignant tumors prevails. To increase more specific tumor uptake or more specific tumor characterization, numerous PET radiopharmaceuticals have been developed, and some of them are being tested in clinical trials. This review will briefly survey the tumor uptake mechanism and clinical significance of representative non-FDG PET radiopharmaceuticals used in clinical trials for patients with cancers.

References

May 1, 1992·Current Problems in Cancer·V C Jordan
Feb 1, 1984·Cancer·J L Wittliff
Jan 1, 1993·Radiology·T OgawaT Okudera
Jan 1, 1996·American Journal of Respiratory and Critical Care Medicine·D A SazonA J Williams
Feb 1, 1997·Radiology·N ShinouraT Hara
Nov 11, 1998·Nature Medicine·A F ShieldsT J Mangner
Mar 10, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P FlamenL Mortelmans
Feb 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V J LoweJ W Fletcher
Jun 2, 2000·Radiographics : a Review Publication of the Radiological Society of North America, Inc·S J SkehanC Nahmias
Jul 25, 2000·Zeitschrift für Kardiologie·M Schwaiger, C Pirich
Jul 27, 2000·The New England Journal of Medicine·R M PietermanH J Groen
Aug 6, 2000·Seminars in Nuclear Medicine·R Bar-ShalomM D Blaufox
Aug 30, 2000·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·M JungehülsingE Stennert
Sep 14, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P FlamenL Mortelmans
Nov 23, 2000·The Journal of Thoracic and Cardiovascular Surgery·P FlamenL Mortelmans
Jan 11, 2001·Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T·R S Liu
Apr 21, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P FlamenL Mortelmans
Jun 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J E MortimerM J Welch
Jun 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W A WeberU Fink

❮ Previous
Next ❯

Citations

Jul 30, 2005·European Journal of Nuclear Medicine and Molecular Imaging·Takako YamaguchiTomio Inoue
Jun 12, 2003·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·Ganghua TangManquan Gan
Dec 7, 2013·Theranostics·Dan J Kadrmas, John M Hoffman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.